-
Something wrong with this record ?
Differential effects of 5-HT3 receptor antagonist on lipid profile in spontaneously hypertensive rat and chromosome 8 congenic strain
M. Krupkova, L. Sedova, F. Liska, D. Krenova, V. Kren, O. Seda,
Language English Country Sweden
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
23183509
Knihovny.cz E-resources
- MeSH
- Hypertension drug therapy genetics metabolism MeSH
- Rats MeSH
- Lipids blood MeSH
- Metabolic Syndrome drug therapy genetics metabolism MeSH
- Disease Models, Animal * MeSH
- Ondansetron pharmacology MeSH
- Polydactyly genetics MeSH
- Glucose Intolerance drug therapy genetics metabolism MeSH
- Rats, Inbred BN MeSH
- Rats, Inbred SHR * MeSH
- Receptors, Serotonin, 5-HT3 genetics metabolism MeSH
- Chromosomes, Mammalian MeSH
- Serotonin 5-HT3 Receptor Antagonists pharmacology MeSH
- Animals, Congenic MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
OBJECTIVES: Ondansetron is an antagonist of 5-HT3 receptors mostly used as an antiemetic yet known to modulate metabolism and appetite. We tested the metabolic effects of ondansetron in newly derived congenic rat strain, carrying limited chromosome 8 regions of (PD) Brown Norway (BN) and polydactylous (PD) strain origins (including variant serotonin receptor Htr3b gene) within the genomic background of highly inbred model of metabolic syndrome, the spontaneously hypertensive rat (SHR). METHODS: Adult, standard diet-fed male rats of SHR and the congenic SHR.(PD/BN)8 strains received ondansetron (2mg/kg body weight/day) or vehicle (n=6/strain/treatment) via oral gavage for 14 days while we followed their metabolic and morphometric profiles including glucose tolerance and triacylgycerol and cholesterol concentrations in 20 lipoprotein fractions. RESULTS: We fine-mapped the chromosome 8 differential segment in the new SHR.(PD/BN)8 congenic strain: it comprises BN-derived region together with an adjacent 422kb stretch of PD origin. The SHR.(PD/BN)8 rats were heavier than SHR, the fasting glucose was significantly higher in ondansetron-treated congenic than in SHR (post-hoc Tukey's HSD p=0.02). Compared to SHR, ondansetron induced significantly more robust increases of cholesterol and triacylglycerol concentrations in total, chylomicron, VLDL and HDL particles in the SHR.(PD/BN)8 congenic strain. CONCLUSION: We established new congenic model with distinct pharmacogenetic profile related to metabolic effects of ondansetron, facilitating thus the search for responsible genetic variants within the limited genomic region demarcated by the differential segment.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13024111
- 003
- CZ-PrNML
- 005
- 20131002123130.0
- 007
- ta
- 008
- 130703s2012 sw f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)23183509
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sw
- 100 1_
- $a Krupkova, Michaela $u Institute of Biology and Medical Genetics, Charles University, Prague, Czech Republic.
- 245 10
- $a Differential effects of 5-HT3 receptor antagonist on lipid profile in spontaneously hypertensive rat and chromosome 8 congenic strain / $c M. Krupkova, L. Sedova, F. Liska, D. Krenova, V. Kren, O. Seda,
- 520 9_
- $a OBJECTIVES: Ondansetron is an antagonist of 5-HT3 receptors mostly used as an antiemetic yet known to modulate metabolism and appetite. We tested the metabolic effects of ondansetron in newly derived congenic rat strain, carrying limited chromosome 8 regions of (PD) Brown Norway (BN) and polydactylous (PD) strain origins (including variant serotonin receptor Htr3b gene) within the genomic background of highly inbred model of metabolic syndrome, the spontaneously hypertensive rat (SHR). METHODS: Adult, standard diet-fed male rats of SHR and the congenic SHR.(PD/BN)8 strains received ondansetron (2mg/kg body weight/day) or vehicle (n=6/strain/treatment) via oral gavage for 14 days while we followed their metabolic and morphometric profiles including glucose tolerance and triacylgycerol and cholesterol concentrations in 20 lipoprotein fractions. RESULTS: We fine-mapped the chromosome 8 differential segment in the new SHR.(PD/BN)8 congenic strain: it comprises BN-derived region together with an adjacent 422kb stretch of PD origin. The SHR.(PD/BN)8 rats were heavier than SHR, the fasting glucose was significantly higher in ondansetron-treated congenic than in SHR (post-hoc Tukey's HSD p=0.02). Compared to SHR, ondansetron induced significantly more robust increases of cholesterol and triacylglycerol concentrations in total, chylomicron, VLDL and HDL particles in the SHR.(PD/BN)8 congenic strain. CONCLUSION: We established new congenic model with distinct pharmacogenetic profile related to metabolic effects of ondansetron, facilitating thus the search for responsible genetic variants within the limited genomic region demarcated by the differential segment.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a zvířata kongenní $7 D020296
- 650 _2
- $a savčí chromozomy $7 D033481
- 650 12
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a porucha glukózové tolerance $x farmakoterapie $x genetika $x metabolismus $7 D018149
- 650 _2
- $a hypertenze $x farmakoterapie $x genetika $x metabolismus $7 D006973
- 650 _2
- $a lipidy $x krev $7 D008055
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a metabolický syndrom $x farmakoterapie $x genetika $x metabolismus $7 D024821
- 650 _2
- $a ondansetron $x farmakologie $7 D017294
- 650 _2
- $a polydaktylie $x genetika $7 D017689
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani inbrední BN $7 D011914
- 650 12
- $a potkani inbrední SHR $7 D011918
- 650 _2
- $a receptory serotoninové 5-HT3 $x genetika $x metabolismus $7 D044406
- 650 _2
- $a serotoninové receptory 5-HT3 - antagonisté $x farmakologie $7 D058831
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Sedova, Lucie $u -
- 700 1_
- $a Liska, Frantisek $u -
- 700 1_
- $a Krenova, Drahomíra $u -
- 700 1_
- $a Kren, Vladimir $u -
- 700 1_
- $a Seda, Ondrej $u -
- 773 0_
- $w MED00168352 $t Neuro endocrinology letters $x 0172-780X $g Roč. 33 Suppl 2(2012), s. 43-9
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23183509 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130703 $b ABA008
- 991 __
- $a 20131002123648 $b ABA008
- 999 __
- $a ok $b bmc $g 987791 $s 822491
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 33 Suppl 2 $d 43-9 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
- LZP __
- $a Pubmed-20130703